{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T10:36:40Z","timestamp":1761561400920},"reference-count":23,"publisher":"Wiley","issue":"9","license":[{"start":{"date-parts":[[2010,2,2]],"date-time":"2010-02-02T00:00:00Z","timestamp":1265068800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Aliment Pharmacol Ther"],"published-print":{"date-parts":[[2010,5]]},"abstract":"<jats:sec><jats:label \/><jats:p> <jats:italic>Aliment Pharmacol Ther<\/jats:italic>\u2002<jats:bold>31<\/jats:bold>, 950\u2013960<\/jats:p><\/jats:sec><jats:sec><jats:title>Summary<\/jats:title><jats:p><jats:bold>Background\u2002<\/jats:bold> Optimal long\u2010term management of symptomatic gastro\u2010oesophageal reflux disease (sGERD) patients has not been established.<\/jats:p><jats:p><jats:bold>Aim\u2002<\/jats:bold> To determine the clinical value of maintenance intermittent treatment with rabeprazole 20\u2003mg vs. placebo in patients with sGERD.<\/jats:p><jats:p><jats:bold>Methods\u2002<\/jats:bold> This multicentre, US study enrolled patients with sGERD (\u22653\u2010month history of GERD symptoms and \u22654\u2003days\/week of heartburn during a 2\u2010week placebo run\u2010in) without oesophageal erosions. Patients with complete heartburn control after 4\u2003weeks of open\u2010label rabeprazole 20\u2003mg daily treatment were randomized to 6\u2010month, double\u2010blind, maintenance intermittent treatment (7\u2010 to 14\u2010day courses when heartburn recurred) with rabeprazole 20\u2003mg or placebo.<\/jats:p><jats:p><jats:bold>Results\u2002<\/jats:bold> The primary efficacy end point, mean percentage of heartburn\u2010free days, was significantly greater with rabeprazole vs. placebo: 82.58% and 62.17% (ITT; <jats:italic>P\u2003<\/jats:italic>&lt;<jats:italic>\u2003<\/jats:italic>0.0001) [per protocol 86.74% rabeprazole vs. 74.93% placebo (<jats:italic>P\u2003<\/jats:italic>&lt;<jats:italic>\u2003<\/jats:italic>0.0254)]. Compared with placebo group, the rabeprazole group also experienced a significantly higher percentage of heartburn\u2010free daytime (84.06% vs. 63.39%; <jats:italic>P\u2003<\/jats:italic>&lt;<jats:italic>\u2003<\/jats:italic>0.0001) and nighttime (95.41% vs. 90.25%; <jats:italic>P\u2003<\/jats:italic>=<jats:italic>\u2003<\/jats:italic>0.0021) periods, had significantly fewer discontinuations because of insufficient heartburn control (6.3% vs. 36.3%; <jats:italic>P\u2003<\/jats:italic>&lt;<jats:italic>\u2003<\/jats:italic>0.0001) and took fewer antacid tablets daily (0.58 vs. 1.16; <jats:italic>P\u2003<\/jats:italic>=<jats:italic>\u2003<\/jats:italic>0.0021).<\/jats:p><jats:p><jats:bold>Conclusion\u2002<\/jats:bold> Intermittent use of rabeprazole may be an effective maintenance treatment strategy for patients with sGERD and warrants further investigation. This trial was registered with <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" xlink:href=\"http:\/\/clinicaltrials.gov\">http:\/\/clinicaltrials.gov<\/jats:ext-link> under the number NCT00165841.<\/jats:p><\/jats:sec>","DOI":"10.1111\/j.1365-2036.2010.04254.x","type":"journal-article","created":{"date-parts":[[2010,2,2]],"date-time":"2010-02-02T08:35:50Z","timestamp":1265099750000},"page":"950-960","source":"Crossref","is-referenced-by-count":10,"title":["Clinical trial: maintenance intermittent therapy with rabeprazole 20\u2003mg in patients with symptomatic gastro\u2010oesophageal reflux disease \u2013 a double\u2010blind, placebo\u2010controlled, randomized study"],"prefix":"10.1111","volume":"31","author":[{"given":"R.","family":"FASS","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"DELEMOS","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"NAZARENO","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"KAO","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"XIANG","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y.","family":"LU","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2010,4,5]]},"reference":[{"key":"e_1_2_6_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9270(03)00009-1"},{"key":"e_1_2_6_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9270(03)00013-3"},{"key":"e_1_2_6_4_2","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD002095.pub3"},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2002.05912.x"},{"key":"e_1_2_6_6_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.1996.44186000.x"},{"key":"e_1_2_6_7_2","doi-asserted-by":"publisher","DOI":"10.3109\/00365529709011212"},{"key":"e_1_2_6_8_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10620-005-3000-3"},{"key":"e_1_2_6_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9270(03)00011-X"},{"key":"e_1_2_6_10_2","doi-asserted-by":"publisher","DOI":"10.1097\/00042737-199802000-00004"},{"key":"e_1_2_6_11_2","first-page":"463","article-title":"Factors influencing compliance in long\u2010term proton pump inhibitor therapy in general practice","volume":"49","author":"Hungin AP","year":"1999","journal-title":"Br J Gen Pract"},{"key":"e_1_2_6_12_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2005.02490.x"},{"key":"e_1_2_6_13_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.1999.00564.x"},{"key":"e_1_2_6_14_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.2001.00943.x"},{"key":"e_1_2_6_15_2","doi-asserted-by":"publisher","DOI":"10.1097\/00042737-200208000-00008"},{"key":"e_1_2_6_16_2","doi-asserted-by":"publisher","DOI":"10.1159\/000087661"},{"key":"e_1_2_6_17_2","doi-asserted-by":"publisher","DOI":"10.1097\/00042737-200509000-00009"},{"key":"e_1_2_6_18_2","first-page":"A137","article-title":"Efficacy of lansoprazole on demand therapy in the treatment of non\u2010erosive reflux disease and functional ulcer\u2010like dyspepsia","volume":"52","author":"Cooper A","year":"2003","journal-title":"Gut"},{"key":"e_1_2_6_19_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2004.01999.x"},{"key":"e_1_2_6_20_2","doi-asserted-by":"publisher","DOI":"10.1023\/B:DDAS.0000034551.39324.c3"},{"key":"e_1_2_6_21_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2005.02413.x"},{"key":"e_1_2_6_22_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.318.7182.502"},{"key":"e_1_2_6_23_2","first-page":"451","article-title":"Long\u2010term prescribing of proton pump inhibitors in general practice","volume":"49","author":"Hungin AP","year":"1999","journal-title":"Br J Gen Pract"},{"key":"e_1_2_6_24_2","doi-asserted-by":"publisher","DOI":"10.2165\/00019053-200523100-00006"}],"container-title":["Alimentary Pharmacology &amp; Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2036.2010.04254.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-2036.2010.04254.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,31]],"date-time":"2023-10-31T20:22:12Z","timestamp":1698783732000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2036.2010.04254.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,4,5]]},"references-count":23,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2010,5]]}},"alternative-id":["10.1111\/j.1365-2036.2010.04254.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-2036.2010.04254.x","archive":["Portico"],"relation":{},"ISSN":["0269-2813","1365-2036"],"issn-type":[{"value":"0269-2813","type":"print"},{"value":"1365-2036","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,4,5]]}}}